A mechanism for effective cell-seeding in rigid, microporous substrates

Bone repair often requires scaffolds to guide tissue regeneration. Porous ceramic scaffolds have been used to support cell infiltration and bone formation. However, the mechanisms by which cells enter rigid, microporous structures remain unclear. Prior research has shown that macroporous scaffolds promote bone growth, but recent findings suggest that microporosity may enhance outcomes further. The role of capillary forces in cellular ingress has not been fully explored. This gap motivated the current study to investigate whether capillary forces could act as a self-seeding mechanism for cells into rigid substrates. Understanding this process could improve scaffold design for clinical applications. The need for a physics-based explanation of cell infiltration is critical for optimizing scaffold performance. This paper addresses a key knowledge gap in tissue engineering and orthopedic research.

This study aimed to explore a novel mechanism for cell infiltration into rigid, microporous scaffolds. The researchers sought to determine if capillary forces could drive cells into microporous networks without external application. The specific problem addressed is the lack of a clear physical explanation for how cells enter such structures. The motivation stems from the observed clinical benefits of microporous scaffolds in bone regeneration. The study also aimed to test whether cell penetration depends on cell size and stiffness. A mathematical model was developed to support the hypothesis. The goal was to provide a framework for tailoring microporosity to specific cell types. This work could lead to improved scaffold designs for bone repair.

The study combined mathematical modeling with in vitro and in vivo experiments. Researchers used CaP-based scaffolds with both macroporosity (>100μm) and microporosity (5-50μm). Cell infiltration was observed in two-dimensional substrates to simulate microporous networks. The model accounted for capillary forces and cell properties such as size and stiffness. In vitro experiments measured cell localization and penetration depth. In vivo experiments confirmed that endogenous cells infiltrate microporous structures. The study compared scaffolds with and without BMP-2 to assess bone regeneration. Results were analyzed to determine the influence of microporosity on cell infiltration. This approach allowed the researchers to test the hypothesis of capillary-driven self-seeding.

Capillary forces were found to draw cells into microporous networks with interconnections smaller than the cell diameter. Cell infiltration depth varied depending on cell size and stiffness. In vitro results showed that cells could penetrate up to specific depths based on their physical properties. The mathematical model supported the hypothesis that capillary forces drive self-seeding. Microporous scaffolds with CaP performed better than BMP-2-containing scaffolds in some bone regeneration metrics. In vivo experiments confirmed that endogenous cells infiltrate microporous networks. The study demonstrated that microporosity can be tailored to optimize cell infiltration for specific cell types. These findings suggest that scaffold design can be improved by adjusting microporosity to match cell characteristics.

The authors propose that capillary forces may underlie the improved bone formation observed in CaP-based scaffolds with microporosity. The study supports the hypothesis that self-seeding occurs through capillary action in both macro- and micropores. The mathematical model and experimental results align with the proposed mechanism. The findings suggest that microporosity can be tailored to specific cell types for optimized infiltration. In vivo results confirm that endogenous cells infiltrate microporous networks. The study highlights the importance of capillary forces in scaffold design for bone repair. These results may inform future scaffold development for clinical applications. The authors suggest that this mechanism could also be relevant for drug delivery systems.